Blog
Will Rivian Automotive (RIVN) Report Negative Earnings Next Week? What You Should Know
The market expects Rivian Automotive (RIVN) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for
Pacira (PCRX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a
Earnings Preview: Resideo Technologies (REZI) Q1 Earnings Expected to Decline
The market expects Resideo Technologies (REZI) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Qualys (QLYS) Earnings Expected to Grow: Should You Buy?
The market expects Qualys (QLYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Ferrari (RACE) Earnings Expected to Grow: Should You Buy?
The market expects Ferrari (RACE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Premier, Inc. (PINC) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Premier, Inc. (PINC) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Lemonade (LMND) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Lemonade (LMND) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Leidos (LDOS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Leidos (LDOS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Par Petroleum (PARR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on lower revenues when Par Petroleum (PARR) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
LCI (LCII) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
LCI (LCII) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good
Analysts Estimate J&J Snack Foods (JJSF) to Report a Decline in Earnings: What to Look Out for
The market expects J&J Snack Foods (JJSF) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Will Lucid Group (LCID) Report Negative Earnings Next Week? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when Lucid Group (LCID) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Jazz Pharmaceuticals (JAZZ) reports results for the quarter ended March 2025. While this widely-known consensus
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
Krystal Biotech, Inc. (KRYS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Earnings Preview: IPG Photonics (IPGP) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when IPG Photonics (IPGP) reports results for the quarter ended March 2025. While this widely-known consensus outlook is
Ingredion (INGR) Earnings Expected to Grow: Should You Buy?
The market expects Ingredion (INGR) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on higher revenues when International General Insurance Holdings Ltd. (IGIC) reports results for the quarter ended March 2025. While this
Intapp (INTA) Earnings Expected to Grow: Should You Buy?
The market expects Intapp (INTA) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is
Will Forge Global Holdings, Inc. (FRGE) Report Negative Q1 Earnings? What You Should Know
Forge Global Holdings, Inc. (FRGE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known
Forrester Research (FORR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Forrester Research (FORR) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Will Genius Sports Limited (GENI) Report Negative Earnings Next Week? What You Should Know
Genius Sports Limited (GENI) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Helios Technologies (HLIO) reports results for the quarter ended March 2025. While this widely-known consensus outlook
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Halozyme Therapeutics (HALO) reports results for the quarter ended March 2025. While this widely-known consensus
Analysts Estimate Datadog (DDOG) to Report a Decline in Earnings: What to Look Out for
The market expects Datadog (DDOG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is